Quest Laborato.

45
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0TNW01017
  • NSEID: QUESTLAB
  • BSEID:
INR
90.75
1.05 (1.17%)
BSENSE

Aug 11, 03:30 PM

BSE+NSE Vol: 15600

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 25.92% vs 33.94% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 2.69% vs 97.32% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 16.21% vs 34.00% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 34.40% vs 100.08% in Mar 2024

Compare Profit and Loss Results of Quest Laborato.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
103.00
101.00
2.00
1.98%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
103.00
101.00
2.00
1.98%
Expenditure (Ex Depriciation)
Stock Adjustments
-4.00
0.00
-4.00
0%
Raw Materials Consumed
83.00
45.00
38.00
84.44%
Power & Fuel Cost
0.00
10.00
-10.00
-100.00%
Employee Cost
4.00
17.00
-13.00
-76.47%
Operating Expenses
0.00
8.00
-8.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
1.00
-1.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
2.00
0.00
0.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
87.00
88.00
-1.00
-1.14%
Operating Profit (PBDIT) excl Other Income
15.00
13.00
2.00
15.38%
Other Income
4.00
0.00
4.00
0%
Operating Profit (PBDIT)
20.00
13.00
7.00
53.85%
Interest
0.00
1.00
-1.00
-100.00%
Profit before Depriciation and Tax
19.00
11.00
8.00
72.73%
Depreciation
0.00
6.00
-6.00
-100.00%
Profit Before Taxation & Exceptional Items
18.00
5.00
13.00
260.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
18.00
4.00
14.00
350.00%
Provision for Tax
5.00
1.00
4.00
400.00%
Profit After Tax
13.00
3.00
10.00
333.33%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
14.00
58.00
-44.00
-75.86%
Profit Available for appropriations
27.00
61.00
-34.00
-55.74%
Appropriations
27.00
61.00
-34.00
-55.74%
Equity Dividend (%)
0%
15%
-15.00
Earnings Per Share
8.28
2.99
5.29
176.92%
Profit And Loss - Net Sales
Net Sales 103.97 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 25.92% vs 33.94% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.98 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2.69% vs 97.32% in Mar 2024

Profit And Loss - Interest
Interest 0.91 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 16.21% vs 34.00% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 13.57 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 34.40% vs 100.08% in Mar 2024